Brief: Odonate Therapeutics Q3 Loss Per Share $0.98
23/10/2018 13:08
Oct 23 (Reuters) - Odonate Therapeutics Inc ODT.O :
* ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE
THREE
AND NINE MONTHS ENDED SEPTEMBER 30, 2018
* Q3 LOSS PER SHARE $0.98
Source text for Eikon: ID:nBw91DSGDa
Further company coverage: ODT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Odonate
See all newsBrief: Odonate Announces Expected Delisting Of Its Stock
Brief: Odonate Therapeutics Announces Planned Return Of Capital To Stockholders Through Share Repurchase Plan
Brief: Odonate Therapeutics Announces Quarterly Loss Per Share Of $0.58
Odonate Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Odonate Therapeutics Inc expected to post a loss of 33 cents a share - Earnings Preview